Ginkgo, Apheris and pharma majors launch 10,000-antibody ML-ready dataset consortium
david_van_dijk · x · 2026-09-30
Ginkgo Datapoints and Apheris launched the Antibody Developability Consortium with founding members AbbVie, argenx, Lundbeck and Takeda, aiming to build the largest ML-ready antibody developability dataset: 10,000 antibodies selected for diversity and characterized to one standard.
- Context: fewer than 250 public IgG sequences have paired developability measurements, and pharma's in-house datasets cluster around their own programs with incompatible assays.
- Approach: a diversity algorithm runs across members' candidate sequences inside Apheris's secure environment.
- Commenter David van Dijk highlights the experiment design: choosing antibodies for diversity first, then measuring uniformly, effectively asks what data a useful model actually needs rather than inheriting whatever was collected.
Related event: Ginkgo and Pharma Partners Launch Antibody Developability Consortium(2 posts)→
More from Research
- Google Research open-sources PaperOrchestra, a multi-agent framework for writing AI papers — google-research · 2026-11-16
- Kind ICLR Reviewer Raises Score Despite Unresolved Concerns, Citing the Paper's Value — MarkSchmidtUBC · 2026-11-16
- Hand-editing 0.2% of weights plus 100 CPU-minutes turns an English TTS model into an 18MB Sanskrit one — kastnerkyle · 2026-11-16
- Why chirality matters for AI for Science: enantiomers behave differently in biology — madeofAjala · 2026-11-16
- RSS 2027 submissions open with FAQ clarifying two-stage review and negative-result bar — GeorgiaChal · 2026-11-16
- Mobile AI Factory: agents auto-build on-device SLMs with 19x less GPU time — pmttyji · 2026-11-16